Upload
igede-eka-widayana
View
224
Download
0
Embed Size (px)
Citation preview
7/27/2019 dwem;ekjefl;kekfelfrmlfg
http://slidepdf.com/reader/full/dwemekjeflkekfelfrmlfg 1/4
Leukocytosis is a condition that affects all types of white blood cells. Other illnesses, such as
neutrophilia, lymphocytosis, and granulocytosis, target specific types of white blood cells. Normal
white blood cell counts are 4,300-10,800 white blood cells per microliter. Leukocyte or white blood
cell levels are considered elevated when they are between 15,000-20,000 per microliter. The
increased number of leukocytes can occur abnormally as a result of an infection, cancer, or drug
intake; however, leukocytosis can occur normally after eating a large meal or experiencing stress.
There are five principal types of leukocytosis :
1. Neutrophilia (the most common form)
2. Monocytosis
3. Eosinophilia
4. Basophilia
Leukocytosis
Leukocytosis is a condition that occurs when the bone marrow produces too many white blood cells. Leukocytosis can occur as a result of bacterial, viral, or parasitic infection, or as a
result of the inflammation that often occurs with disorders such as osteoarthritis. Physical or
emotional stress, medication side effects, strong immune reactions, or disorders of the bone
marrow can also cause this disorder. Symptoms can vary, depending on the cause of the
disorder, but often include fever, fatigue, and weakness. Treatment can also vary, depending
on the cause of the disorder.
A number of health factors can contribute to elevated white blood cell counts. Often,
abnormally high white blood cell counts occur due to infection, since white blood cells are
the immune cells responsible for fighting bacteria, viruses and other pathogens inside the
body. Inflammation, such as that caused by osteoarthritis, can also lead to increased white
blood cell production. Damage to bodily tissues often results in a similar immune reaction, as
can allergies or asthma.
Extreme emotional and physical stress can also lead to a raised white blood cell count.
Certain prescription medications can cause leukocytosis as a side effect. Disorders of the
bone marrow, including leukemia, thrombocytopenia and myelofibrosis can lead to elevatedwhite blood cell counts.
Symptoms of leukocytosis can vary widely, depending upon the underlying cause of the
disease. Certain symptoms, however, can occur no matter what the cause of leukocytosis.
These symptoms include excessive bleeding or bruising, fever, lethargy and weakness,
dizziness, sweating, and fainting. Tingling pain might occur in the legs, arms, or abdomen.
Vision problems, confusion and difficulty breathing can occur, along with weight loss and
lowered appetite.
7/27/2019 dwem;ekjefl;kekfelfrmlfg
http://slidepdf.com/reader/full/dwemekjeflkekfelfrmlfg 2/4
Eosinophilia
Eosinophils are white blood cells that participate in immunologic and allergic events.
Common causes of eosinophilia are listed in Table . The relative frequency of each causeusually relates to the clinical setting. For example, parasitic infections are often responsible
for eosinophilia in pediatric patients, and drug reactions commonly cause an increased
eosinophil count in hospitalized patients. Dermatologists frequently find eosinophilia in
patients with skin rashes, and pulmonologists often see elevated numbers of eosinophils in
conjunction with pulmonary infiltrates and bronchoallergic reactions.
A complete blood count (CBC) can often be used to definitively diagnose leukocytosis by
pinpointing a patient's white blood cell count. A peripheral blood smear (PBS) might be
necessary if bone marrow disorders are suspected. These tests can help doctors look for
abnormalities in the white blood cells.
Treatment usually seeks to resolve the underlying cause of leukocytosis. In some cases, such
as in the case of infection, no treatment is necessary, as leukocytosis will generally resolve
itself when the infection is treated or runs its course. Steroids, antibiotics, and drugs to reduce
blood levels of uric acid can help treat leukocytosis. Where bone marrow disorders are the
cause of leukocytosis, bone marrow transplants, blood transfusions, and chemotherapy can beused to help treat leukocytosis.
Other causes of eosinophilia include malignancies, especially those affecting the immune
system (Hodgkin's disease and non-Hodgkin's lymphoma),and immunologic disorders such
as rheumatoid arthritis and periarteritis. Eosinophilia-myalgia syndrome, a recently described
disorder associated with dietary supplements of tryptophan, resembles a connective tissue
disease with fibrosis of muscle fascial tissue and peripheral eosinophilia
Bashopilia
Basophilia is an uncommon cause of leukocytosis. Basophils are inflammatory mediators of
substances such as histamine. These cells, along with similar tissue-based cells (mast cells),
have receptors for IgE and participate in the degranulation of white blood cells that occurs
during allergic reactions, including anaphylaxis.
Monocytosis
Monocytosis is an increase in the number of monocytes circulating in the blood.[1]
Monocytes are white blood cells that give rise to macrophages and dendritic cells in the
immune system.
In humans, 950/μL is regarded as at the upper limit of normal; monocyte counts above this
level are regarded as monocytosis
Monocytosis often occurs during chronic inflammation. Diseases that produce this state:
7/27/2019 dwem;ekjefl;kekfelfrmlfg
http://slidepdf.com/reader/full/dwemekjeflkekfelfrmlfg 3/4
Infections: tuberculosis, brucellosis, listeriosis, subacute bacterial endocarditis,
syphilis, and other viral infections and many protozoal and rickettsial infections (e.g.
kala azar, malaria, Rocky Mountain spotted fever).
Blood and immune causes: chronic neutropenia and myeloproliferative disorders.
Autoimmune diseases and vasculitis: systemic lupus erythematosus, rheumatoid
arthritis and inflammatory bowel disease. Malignancies: Hodgkin's disease and certain leukaemias, such as chronic
myelomonocytic leukaemia (CMML) and monocytic leukemia.
Recovery phase of neutropenia or an acute infection.
Miscellaneous causes: sarcoidosis and lipid storage disease.
Hodgkin lymphoma, also known as Hodgkin's lymphoma and Hodgkin's disease is a type of
lymphoma, which is a cancer originating from white blood cells called lymphocytes. It wasnamed after Thomas Hodgkin, who first described abnormalities in the lymph system in
1832.[2][3]
Hodgkin's lymphoma is characterized by the orderly spread of disease from one lymph node
group to another and by the development of systemic symptoms with advanced disease.When Hodgkins cells are examined microscopically, multinucleated Reed – Sternberg cells
(RS cells) are the characteristic histopathologic finding.
Hodgkin's lymphoma may be treated with radiation therapy, chemotherapy, or hematopoietic
stem cell transplantation, with the choice of treatment depending on the age and sex of the
patient and the stage, bulk, and histological subtype of the disease. The disease occurrence
shows two peaks: the first in young adulthood (age 15 – 35) and the second in those over 55
years old.
The overall 5-year relative survival for 2001 – 2007 from 17 SEER geographic areas was
83.9%. Since many patients are young, they often live 40 years or more after treatment.
However, few studies follow patients as long as 25 years, and those studies are of older
treatments with more life-threatening adverse effects. There is insufficient data available
about the long-term outcomes of newer, less-toxic regimens and ones which limit radiation
exposure. Radiation treatments, and some chemotherapy drugs, pose a risk of causing
potentially fatal secondary cancers, heart disease, and lung disease 40 or more years later.Modern treatments greatly minimize the chances of these late effects.
Patients with a history of infectious mononucleosis because of Epstein – Barr virus (EBV) may
have an increased risk of HL, but the precise contribution of Epstein – Barr virus remains
largely unknown.
7/27/2019 dwem;ekjefl;kekfelfrmlfg
http://slidepdf.com/reader/full/dwemekjeflkekfelfrmlfg 4/4